Table 1.
Preventive service | Definition of eligibility | Definition of utilization |
---|---|---|
Tobacco cessation23 | Current smoker | Former smoker |
Obesity control24,25 | BMI ≥30 kg/m2 | Weight loss of ≥5%a |
Hypertension control26 | Blood pressure ≥140/90 mmHgb | Blood pressure <140/90 mmHgb |
Lipids control27,28 | LDL-C ≥130 mg/dL for non-diabetics, ≥100 mg/dL for diabeticsc | LDL <130 mg/dL for non-diabetics, <100 mg/dL for diabeticsc |
Blood glucose control29 | Diagnosis with diabetes and HbA1c ≥7% | HbA1c <7.0% |
Breast cancer screening30 | Women with no mammogram in past 2 years, in women without bilateral mastectomy | Receipt of mammography |
Cervical cancer screening31 | In women aged <65 years and without prior hysterectomy, no Pap test in past 3 years or no Pap+HPV co-testing in past 5 years | Pap test, with or without HPV testing |
Colorectal cancer screening32 | Colonoscopy in past 10 years, flexible sigmoidoscopy in past 5 years, or fecal occult blood testing in past 1 year | Receipt of colonoscopy, flexible sigmoidoscopy or fecal occult blood testing |
Abdominal aortic aneurysm screening33 | Men aged 65–75 years who ever smoked with no record of screening | Receipt of screening |
Osteoporosis screening34 | Women aged ≥65 years | Receipt of osteoporosis screening |
Influenza vaccination | All individuals | Receipt of influenza vaccine |
Weight loss ≥10% in sensitivity analysis.
Average of three latest visits in each calendar year, if they occurred within 90 days of each other.
Based on ATP III criteria,28 which were in place during the majority of this study.
LDL-C, low density lipoprotein cholesterol; HPV, human papilloma virus; ATP III, Adult Treatment Panel III; HbA1c, glycated hemoglobin.